![CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F2162-3619-1-36/MediaObjects/40164_2012_Article_34_Fig2_HTML.jpg)
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
![Cells | Free Full-Text | Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR Cells | Free Full-Text | Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR](https://www.mdpi.com/cells/cells-10-03208/article_deploy/html/images/cells-10-03208-g001-550.jpg)
Cells | Free Full-Text | Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR
![Expression of a Novel Chimeric Inhibitory Receptor Attenuates CD19 CAR T Cells: A Promising Strategy for Toxicity Mitigation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Expression of a Novel Chimeric Inhibitory Receptor Attenuates CD19 CAR T Cells: A Promising Strategy for Toxicity Mitigation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and](https://www.astctjournal.org/cms/asset/797dc693-6748-4743-b11c-0b0c6ad7d745/gr5.jpg)
Expression of a Novel Chimeric Inhibitory Receptor Attenuates CD19 CAR T Cells: A Promising Strategy for Toxicity Mitigation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and
![Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity](https://www.mdpi.com/cancers/cancers-13-01401/article_deploy/html/images/cancers-13-01401-g001.png)
Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity
of CD19 and CD20 expression during B cell development. CD19 expression... | Download Scientific Diagram
![Expression of CD5 and CD19 markers in B-cells of patients with chronic... | Download Scientific Diagram Expression of CD5 and CD19 markers in B-cells of patients with chronic... | Download Scientific Diagram](https://www.researchgate.net/publication/313463302/figure/fig1/AS:459503008260099@1486565463178/Expression-of-CD5-and-CD19-markers-in-B-cells-of-patients-with-chronic-lymphocytic.png)
Expression of CD5 and CD19 markers in B-cells of patients with chronic... | Download Scientific Diagram
![CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F2162-3619-1-36/MediaObjects/40164_2012_Article_34_Fig1_HTML.jpg)
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
![Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-21168-6/MediaObjects/41467_2021_21168_Fig1_HTML.png)
Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications
![Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies](https://www.frontiersin.org/files/MyHome%20Article%20Library/495638/495638_Thumb_400.jpg)